InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.82
(
1.02%
)
Bitcoin
69,906.47
(
2.04%
)
Post# of 13742
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

~MulaGreen~

Send PM Follow Ignore
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

~MulaGreen~

Re: None

Friday, 05/21/2021 8:57:05 AM

Friday, May 21, 2021 8:57:05 AM

Post# of 13742
FDA IND when Approved...the FDA will designate IND status for Escozine®, essentially allowing the drug to be distributed in the US.

https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html

After such designation, the Company will pursue other clinical applications of Escozine®, including as a potential cancer therapeutic where the Company has already released positive clinical results.

Ask Mr.Google to Xnslate it for you (other Language)...if u r having a problem reading and understanding it.
It is written in American not English.me thinks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up